SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2012 / Cilt: 60 - Sayı: 4

The third primary-the second metachronous lung cancer in the same patient

Aynı hastada üçüncü primer-ikinci metakron akciğer kanseri

Sadi KAYA
Abdulkadir KÜÇÜKBAYRAK
Koray AYDOĞDU
Seray HAZER
Göktürk FINDIK
Pages
365–369
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reported this case because of a second metachronous tumour in the same patient has not been reported before and to emphasize the effects of postoperative follow up on the prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Having more than one lung carcinoma in an organism is called as multiple primary lung carcinoma.
📊
Key Findings & Data:A sychronous mass was determined on a 67 years old man about eight years ago.
💡
Conclusion & Impact:We reported this case because of a second metachronous tumour in the same patient has not been reported before and to emphasize the effects of postoperative follow up on the prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Having more than one lung carcinoma in an organism is called as multiple primary lung carcinoma. The probability of having a second primary lung carcinoma in the same patient at the different times is very rare.Third primary lung carcinoma has not been reported in literature before. A sychronous mass was determined on a 67 years old man about eight years ago. The mass was localized on the left upper lobe and it s histologic type was squamous cell carcinoma/adenosquamous cell carcinoma (bronchioalveolar component). A left upper lobectmy was performed with a left thorocotomy. Thirty nine months after that operation a metachronous epidermoid carcinoma was determined on the right upper lobe, consequently a right upper lobectomy was performed to him. A squamous cell carcinoma was determined on the right intermedier bronch as a third time and second metachronous 49 months later after the first operation. After all he underwent chemotherapy. We reported this case because of a second metachronous tumour in the same patient has not been reported before and to emphasize the effects of postoperative follow up on the prognosis.

Özet

Organizmada birden fazla akciğer tümörünün bulunmasına multipl primer akciğer kanseri denilmektedir. Aynı hastada farklı zamanlarda ikinci primer akciğer kanseri olması ihtimali oldukça nadirdir, üçüncü primer akciğer kanseri ise literatürde sunulmamıştır. Altmış yedi yaşında erkek hastada sekiz yıl önce senkron kitle tespit edildi. Kitle sol akciğer üst lobda ve histolojik olarak skuamöz hücreli karsinoma/adenoskuamöz hücreli karsinoma (bronkoalveoler komponentli) idi. Hastaya sol üst lobektomi yapıldı. Bundan 39 ay sonra sağ üst lobda metakron olarak epidermoid karsinom tespit edildi ve sağ üst lobektomi yapıldı. Hastada üçüncü kez, ikinci metakron olarak ve 49 ay sonra, sağ intermedier bronşta skuamöz hücreli karsinom tespit edildi. Hasta kemoterapi protokolüne alındı. Malign hastalarda takibin önemi bilinmektedir. Olgumuzu daha önce aynı hastada ikinci metakron tümör yayınlanmadığı için ve hasta takibinin prognoz üzerindeki etkisini pekiştirmek açısından sunuyoruz.

🔖

Cite This Article

KAYA, S., KÜÇÜKBAYRAK, A., AYDOĞDU, K., HAZER, S., FINDIK, G. (2022). The third primary-the second metachronous lung cancer in the same patient. Tüberküloz ve Toraks, Cilt: 60 - Sayı: 4, 365–369. https://ajindex.com/articles/618700

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Rea F, Zuin A, Callegaro D, Bortolotti L, Guanella G, Sartori F. Surgical results for multiple primary-lung cancers. Eur J Cardiothorac Surg 2001; 20: 489-95
  2. Nakata M, Sawada S, Yamashita M, Saeki H, Kurita A, Takashima S, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg 2004; 78: 1194-9
  3. Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg 1990; 99: 769-78
  4. Fraser RS, Colman N, Müller NL, Pare PD. Fraser et Pare’s diagnosis of disease of the chest. 4th ed. Philadelphia: WB Saunders Company, 1999: 1201
  5. Özşeker F, Bilgin S, Baran A, Dilek İ, Bayram Ü, Akkaya E. Second primary lung cancers. Solunum Hastalıkları 2003; 14: 239-44
  6. Zhao J, Zhang DC, Wang LJ, Zhang RJ. Diagnosis and treatment of multiple primary lung cancers. Ai Zhang 2002; 21: 764-7
  7. Yılmaz A, Bayramgürler B, Ünver E, Okur H. Synchronous primary lung cancer. Toraks Dergisi 2001; 2: 53-5
  8. Wu S, Lin Z, Xu CW, Koo KS, Huang OL, Xie DQ. Multiple primary lung cancers. Chest 1987; 92: 892-6
  9. Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg 1995; 59: 863-7
  10. Tuksavul F, Aktoğu S, Güçlü SZ, Ermete S, Kasal A. Multiple primary bronchial carcinoma. Solunum 1996; 20: 641-5
  11. Durmaz G, Kalaycıoğlu O, Moğulkoç G. Second primary lung malignancies (three case report). Tuberk Toraks 1996; 44: 30- 4
  12. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70: 606-12
  13. Van Rens M, Eijken EJ, Elbers JRJ, Lammers JW, Tilanus MG, Slootweg, PJ. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma. Cancer 2002; 94: 188-96
  14. Carey FA, Donnelly SC, Walker WS, Cameron EW, Lamb D. Synchronous primary lung cancers: prevalence in surgical material and clinical implications. Thorax 1993; 48: 344-6
  15. Coffman B, Crum E, Forman WB. Two primary carcinomas of the lung: adenocarcinoma and a metachronous squamous cell carcinoma. Cancer 1983; 51: 124-6
  16. Sahoo R, Acharya VK, Kasturi DP, Lobo FD, Kini H. Second primary lung cancer with tuberculosis. Indian J Chest Dis Allied Sci 2006; 48: 63-6
  17. Tokat AO, Güngör A. Synchoronous lung carcinomas. T Klin J Med Sci 2003; 23: 63-6
  18. Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest 1997; 112: 693-701
  19. Detterbeck FC, Jones DR, Kernstine KH, Nau